⌘K

Login Start Free

Home/Filings/4/0001179110-09-002257

4//SEC Filing

Kaldjian Eric P 4

Accession 0001179110-09-002257

CIK 0001043961other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 12:28 PM ET

Size

9.7 KB

Accession

0001179110-09-002257

Insider Transaction Report

Form 4

Period: 2008-12-09

TRANSGENOMIC INCTBIO

Kaldjian Eric P

Chief Scientific Officer

Transactions

Award
Purchase Option
2008-12-09+33,333→ 266,667 total
Exercise: $0.56From: 2011-01-01Exp: 2020-12-08→ Common Stock (33,333 underlying)
Award
Purchase Option
2008-12-09+33,333→ 300,000 total
Exercise: $0.56From: 2012-01-01Exp: 2020-12-08→ Common Stock (33,333 underlying)
Award
Purchase Option
2008-12-09+33,334→ 233,334 total
Exercise: $0.56From: 2010-01-01Exp: 2020-12-08→ Common Stock (33,334 underlying)

Footnotes (1)

[F1]Common Stock, par value $.01 per share of Transgenomic, Inc.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

TRANSGENOMIC INC

CIK 0001043961

Entity typeother

Related Parties

1

filerCIK 0001435747

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 12:28 PM ET
Size: 9.7 KB

View on SEC.gov